The FDA broadened dupilumab's (Dupixent) approval as an add-on maintenance treatment for chronic rhinosinusitis with nasal polyps to include adolescents as well, Regeneron Pharmaceuticals and Sanofi ...

TARRYTOWN, N.Y. and PARIS, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Please provide your email address to receive an email when new articles are posted on . Dupilumab is the first treatment in the U.S. for CRSwNP for adolescents. The approval is supported by data from ...

Often the worst symptoms of nasal polyps happen when they grow large or you have multiple nasal polyps. Infection is more common when this happens. Certain medications work specifically to shrink ...

Nasal polyps are soft growths that can develop in your nose as a result of long-term swelling — from colds, allergies, and other conditions — in your nasal passages. They are more common in people who ...

Experts share their thoughts on the link between these respiratory conditions and what it means for treatment. Nasal polyps are small, noncancerous growths that develop inside the nasal canal. They ...

You may develop nasal polyps when your nasal passages or sinuses are constantly irritated and swollen. These soft, noncancerous growths can be found in nasal passages and sinuses and form from the ...

CRSwNP often coexists with asthma, complicating treatment and reducing health-related quality of life. Standard therapies for CRSwNP, like nasal irrigation and corticosteroids, often inadequately ...

Nasal polyps are small noncancerous growths in the nose or sinuses. They may cause pain or pressure in the face, runny or stuffy nose, and other symptoms or complications that may negatively affect ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use has recommended the granting of a marketing authorization for Exdensur (depemokimab, GlaxoSmithKline) for severe ...